Human ADAM Like Decysin 1 (ADAMDEC1) Protein
390€ (10 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Human ADAM Like Decysin 1 (ADAMDEC1) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx690102
tested applications
SDS-PAGE
Description
Human ADAM-like Protein is a recombinant protein from Human produced in Human Cells. Recombinant Human ADAM-like protein decysin-1 is produced by our Mammalian expression system and the target gene encoding Lys206-Glu470 is expressed with a 6His tag at the C-terminus.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | ADAM-like |
| Host | Human |
| Origin | Human |
| Observed MW | Molecular Weight: 30.3 kDa Sequence Fragment: Lys206-Glu470 Tag: C-terminal 6 His tag Validity: The validity for this protein is 6 months. |
| Expression | Recombinant |
| Purity | > 95% (SDS-PAGE) |
| Size 1 | 10 µg |
| Size 2 | 50 µg |
| Form | |
| Tested Applications | SDS-PAGE |
| Buffer | 20mM TrisHCl, 150mM NaCl, 1mM ZnCl2, pH7.5. |
| Availability | Shipped within 5-15 working days. |
| Storage | Aliquot and store at < -20 °C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | O15204 |
| Alias | ADAM DEC1 |
| Background | Protein ADAMDEC1 |
| Status | RUO |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
ADAM Like Decysin 1 (ADAMDEC1) is a member of the ADAM (a disintegrin and metalloprotease) family of proteins, which are involved in proteolysis and cell-cell or cell-matrix interactions. Unlike most ADAM proteins, ADAMDEC1 lacks a transmembrane domain, making it a secreted protein. It is primarily expressed in immune-related tissues, such as lymph nodes, the colon, and macrophages, where it is thought to participate in immune response regulation and extracellular matrix remodeling. ADAMDEC1 is involved in degrading extracellular matrix proteins, potentially playing a role in inflammation, tissue remodeling, and immune surveillance. Dysregulation of ADAMDEC1 has been associated with inflammatory conditions and cancer, where altered extracellular matrix remodeling contributes to tumor invasion and metastasis. Emerging research focuses on its role in modulating immune cell activity and its potential as a biomarker or therapeutic target in inflammatory and oncological diseases.
Related Products
anti- ADAMDEC1 antibody
May play an important role in the control of the immune response and during pregnancy.
Ver Producto
Recombinant Human ADAMDEC1
Ver Producto